ALX Oncology Holdings Inc.ALXONASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank44
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P44
Within normal range
vs 3Y Ago
-0.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-2.17%
Q3 202515.45%
Q2 202516.25%
Q1 2025-3.94%
Q4 20246.00%
Q3 202421.57%
Q2 2024-9.97%
Q1 202421.37%
Q4 20239.86%
Q3 2023-44.86%
Q2 2023-14.20%
Q1 20230.05%
Q4 202212.16%
Q3 2022-8.56%
Q2 2022-36.54%
Q1 202213.08%
Q4 2021-15.85%
Q3 2021-50.78%
Q2 2021-14.72%
Q1 202120.29%
Q4 2020-81.72%
Q3 20209.07%
Q2 2020-105.78%
Q1 202032.21%
Q4 2019-154.88%
Q3 201927.57%
Q2 20190.90%
Q1 20190.00%